Bausch Health Companies (BHC) Shares Outstanding (Diluted Average) (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Shares Outstanding (Diluted Average) came in at $372.8 million in Q1 2026, up 0.87% year-on-year from $369.6 million in Q1 2025, and down 0.59% quarter-over-quarter from $375.0 million in Q4 2025.

Bausch Health Companies (BHC) Shares Outstanding (Diluted Average) (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Shares Outstanding (Diluted Average) across 16 years of filings, most recently posting $372.8 million for Q1 2026.

  • Shares Outstanding (Diluted Average) for Q1 2026 came in at $372.8 million, up 0.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $372.8 million (up 0.87% YoY), and the FY2025 annual result was $375.0 million, up 1.9% from the prior year.
  • Shares Outstanding (Diluted Average) came in at $372.8 million for Q1 2026 at Bausch Health Companies, down from $375.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $375.5 million in Q3 2025 to a low of $360.8 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Diluted Average) is $366.8 million (2024), against an average of $367.4 million.
  • Across the five-year window, Shares Outstanding (Diluted Average) decreased 0.08% in 2022 and grew 2.12% in 2025, its largest moves.
  • Bausch Health Companies' Shares Outstanding (Diluted Average) stood at $362.0 million in 2022, then climbed by 0.8% to $364.9 million in 2023, then grew by 0.85% to $368.0 million in 2024, then climbed by 1.9% to $375.0 million in 2025, then decreased by 0.59% to $372.8 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $372.8 million (Q1 2026), $375.0 million (Q4 2025), and $375.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.18 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 422.40 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 47.20 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 103.40 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 506.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 228.36 Mn
10 Bausch Health Companies 1.91 Bn 1.58 Bn 2.48 Bn 372.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 372.80 Mn
Dec 31, 2025 375.00 Mn
Sep 30, 2025 375.50 Mn
Jun 30, 2025 373.10 Mn
Mar 31, 2025 369.60 Mn
Dec 31, 2024 368.00 Mn
Sep 30, 2024 367.70 Mn
Jun 30, 2024 370.20 Mn
Mar 31, 2024 366.80 Mn
Dec 31, 2023 364.90 Mn
Sep 30, 2023 365.40 Mn
Jun 30, 2023 364.10 Mn
Mar 31, 2023 363.30 Mn
Dec 31, 2022 362.00 Mn
Sep 30, 2022 363.70 Mn
Jun 30, 2022 362.20 Mn
Mar 31, 2022 360.80 Mn
Dec 31, 2021 358.90 Mn
Sep 30, 2021 364.00 Mn
Jun 30, 2021 358.00 Mn